Mussa G C, Silvestro L, Barberis L, Operti B, Mussa F
Istituto di Puericultura, Università di Torino.
Minerva Pediatr. 1991 May;43(5):357-70.
The aim of this study was to assess the diagnostic sensitivity and specificity of hepatobiliary scintigraphy using a 99mTc-HIDA compound to differentiate intrahepatic cholestasis from extrahepatic forms during the first months of life. The tracer used was acid N-(2,6)-diethylacetanylido-iminodiacetic (diethyl-HIDA) with almost exclusively biliary excretion and a high concentration of radioactivity in the bile. Each neonate was injected with 0.5 mg/kg i.v. of the compound marked with a dose of 99mTc equivalent to 80-100 microCi/kg. Scintigraphic recordings were carried out every 10' for the first hour and further controls were performed at 2, 3, 4, 8 and 24 hours. Scintiphotos were obtained using a Polaroid scintillation camera, PHO Gamma V. Fifty-four patients were included in the study (34 males and 20 females) aged between 4 days and 3 months old. All patients were clinically suspected of pathologies involving the hepatobiliary tract. All cases were affected by persistent jaundice (total bilirubin between 1.8 and 39.6 mg%) with predominantly direct bilirubin (range 1.5-26.2 mg%), acholic feces and hyperchromic urine. Hepato-biliary scintigraphy revealed an intestinal excretion of tracer in 31 out of the 54 neonates examined, excluding the presence of an extrahepatic obstruction of the biliary tract. On the other hand, only 13 out of 23 cases in which no enteric excretion of the tracer was observed, was the final diagnosis one extrahepatic cholestasis. Scintigraphic tests therefore showed a 100% sensitivity associated with a specificity of only 56.52%. This demonstrates that the finding of tracer in the intestine is pathognomonic of the permeability of extrahepatic biliary ducts and that biliary atresia can be ruled out. On the contrary, the absence of the intestinal excretion of the tracer is nor constantly associated with biliary atresia. This study has confirmed this finding in 10 cases of intrahepatic cholestasis (4 hypoplasias of the intrahepatic biliary tract, 3 thick bile syndromes, 3 cases of hepatitis due to cytomegalovirus). In conclusion, the Authors state that hepato-biliary scintigraphy represents a straightforward and non-invasive diagnostic method which enables the permeability of the biliary tract to be assessed in subjects with jaundice.
本研究的目的是评估使用99mTc-HIDA化合物进行肝胆闪烁显像在生命最初几个月区分肝内胆汁淤积和肝外胆汁淤积的诊断敏感性和特异性。所使用的示踪剂是酸性N-(2,6)-二乙基乙酰苯胺亚氨基二乙酸(二乙基-HIDA),其几乎完全通过胆汁排泄且胆汁中放射性浓度高。每例新生儿静脉注射0.5mg/kg该化合物,其标记的99mTc剂量相当于80 - 100微居里/千克。在最初1小时内每10分钟进行一次闪烁显像记录,并在2、3、4、8和24小时进行进一步检查。使用宝丽来闪烁相机PHO Gamma V获取闪烁照片。54例患者纳入研究(34例男性和20例女性),年龄在4天至3个月之间。所有患者临床上均怀疑患有涉及肝胆道的疾病。所有病例均有持续性黄疸(总胆红素在1.8至39.6mg%之间),以直接胆红素为主(范围为1.5至26.2mg%),粪便无胆汁且尿液色深。在54例接受检查的新生儿中,肝胆闪烁显像显示31例示踪剂有肠道排泄,排除了存在肝外胆道梗阻。另一方面,在23例未观察到示踪剂肠道排泄的病例中,最终诊断为肝外胆汁淤积的仅13例。因此,闪烁显像检查显示敏感性为100%,而特异性仅为56.52%。这表明在肠道中发现示踪剂是肝外胆管通畅的特征性表现,可排除胆道闭锁。相反,示踪剂无肠道排泄并不总是与胆道闭锁相关。本研究在10例肝内胆汁淤积病例(4例肝内胆管发育不全、3例浓稠胆汁综合征、3例巨细胞病毒肝炎)中证实了这一发现。总之,作者指出肝胆闪烁显像代表一种简单且非侵入性的诊断方法,能够评估黄疸患者的胆道通畅情况。